CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Stock Options	Common Stock	Additional paid-In capital	Additional paid-In capital Stock Options	Retained earnings	Accumulated other comprehensive income (loss)	Treasury Stock
Balance, beginning of the period (in shares) at Mar. 31, 2022			149,840,925
Balance, beginning of the period at Mar. 31, 2022	$ 1,063,060		$ 14,984	$ 1,721,118		$ 1,420,993	$ 5,730	$ (2,099,765)
Treasury stock, beginning balance (in shares) at Mar. 31, 2022								(81,205,596)
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances (in shares)			399,146					(101,011)
Employee stock awards, benefit plans and other issuances	3,987		$ 40	6,219				$ (2,272)
Non-cash stock-based compensation (in shares)			47,093
Non-cash stock-based compensation	117,351		$ 5	117,346
Restricted stock units vested (in shares)			3,253,815
Restricted stock units vested	0		$ 325	(325)
Liability-classified restricted stock units vested (in shares)			446,805
Liability-classified restricted stock units vested	11,603		$ 45	11,558
Acquisition of treasury stock (in shares)								(6,066,230)
Acquisition of treasury stock	(149,997)							$ (149,997)
Comprehensive income (loss):
Foreign currency translation	(1,226)						(1,226)
Net earnings (loss)	(118,702)					(118,702)
Balance, end of the period (in shares) at Mar. 31, 2023			153,987,784
Balance, end of the period at Mar. 31, 2023	926,076		$ 15,399	1,855,916		1,302,291	4,504	$ (2,252,034)
Treasury stock, ending balance (in shares) at Mar. 31, 2023								(87,372,837)
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances (in shares)			369,442					(219,270)
Employee stock awards, benefit plans and other issuances	1,387		$ 38	7,184				$ (5,835)
Non-cash stock-based compensation (in shares)			39,174
Non-cash stock-based compensation	68,057		$ 3	68,054
Restricted stock units vested (in shares)			1,427,305
Restricted stock units vested	0		$ 143	(143)
Acquisition-related restricted stock award/replacement of stock options (in shares)			36,118
Acquisition-related restricted stock award/replacement of stock options	0	$ 493	$ 3	(3)	$ 493
Liability-classified restricted stock units vested (in shares)			83,439
Liability-classified restricted stock units vested	2,283		$ 8	2,275
Acquisition of treasury stock (in shares)								(2,076,854)
Acquisition of treasury stock	(60,502)							$ (60,502)
Comprehensive income (loss):
Foreign currency translation	(540)						(540)
Net earnings (loss)	11,881					11,881
Balance, end of the period (in shares) at Mar. 31, 2024			155,943,262
Balance, end of the period at Mar. 31, 2024	$ 949,135		$ 15,594	1,933,776		1,314,172	3,964	$ (2,318,371)
Treasury stock, ending balance (in shares) at Mar. 31, 2024	(89,700,000)							(89,668,961)
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances (in shares)			422,840					(329,582)
Employee stock awards, benefit plans and other issuances	$ (1,499)		$ 43	8,790				$ (10,332)
Non-cash stock-based compensation (in shares)			38,201
Non-cash stock-based compensation	103,031		$ 4	103,027
Restricted stock units vested (in shares)			2,772,149
Restricted stock units vested	0		$ 277	(277)
Acquisition of treasury stock (in shares)								(3,762,416)
Acquisition of treasury stock	(101,325)							$ (101,325)
Comprehensive income (loss):
Foreign currency translation	331						331
Net earnings (loss)	(814)					(814)
Balance, end of the period (in shares) at Mar. 31, 2025			159,176,452
Balance, end of the period at Mar. 31, 2025	$ 948,859		$ 15,918	$ 2,045,316		$ 1,313,358	$ 4,295	$ (2,430,028)
Treasury stock, ending balance (in shares) at Mar. 31, 2025	(93,800,000)							(93,760,959)